Tandem Diabetes Care (TNDM) Capital Expenditures (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Capital Expenditures came in at $6.3 million in Q1 2026, up 111.4% YoY from $3.0 million in Q1 2025, and down 6.24% on a QoQ basis from $6.7 million in Q4 2025.
Tandem Diabetes Care (TNDM) Capital Expenditures (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Capital Expenditures data on file, last reported at $6.3 million in Q1 2026.
- Quarterly Capital Expenditures rose 111.4% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.3 million (up 2135.99% YoY) and the FY2025 annual result came in at $19.9 million, up 2333.82% from the prior year.
- Capital Expenditures eased to $6.3 million in Q1 2026, from $6.7 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $12.2 million in Q3 2025 to a low of -$17.1 million in Q4 2024.
- A 5-year average of $1.7 million and a median of $3.0 million in 2025 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 3323.53% in 2022, down 5800.0% in 2022.
- Tracing TNDM's Capital Expenditures over 5 years: stood at $247000.0 in 2022, then jumped by 600.4% to $1.7 million in 2023, then slumped by 1085.84% to -$17.1 million in 2024, then surged by 139.2% to $6.7 million in 2025, then fell by 6.24% to $6.3 million in 2026.
- The last three Capital Expenditures figures came in at $6.3 million (Q1 2026), $6.7 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Mn |
| Jun 30, 2026 | 2.61 Mn |
| Mar 31, 2026 | 6.27 Mn |
| Mar 31, 2026 | 6.27 Mn |
| Dec 31, 2025 | 6.69 Mn |
| Dec 31, 2025 | 6.69 Mn |
| Sep 30, 2025 | 12.19 Mn |
| Sep 30, 2025 | 12.19 Mn |
| Jun 30, 2025 | -1.89 Mn |
| Jun 30, 2025 | -1.89 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | -17.06 Mn |
| Dec 31, 2024 | -17.06 Mn |
| Sep 30, 2024 | 5.24 Mn |
| Sep 30, 2024 | 5.24 Mn |
| Jun 30, 2024 | 7.71 Mn |
| Jun 30, 2024 | 7.71 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Mar 31, 2024 | 3.21 Mn |